Ticker Scorecard - ADVM Basics Company: Adverum Biotechnologies, Inc. IPO Date: May 12, 2016 Sector: Healthcare Industry: Biotech Market Cap: $98.6M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.57% Avg Daily Range (30 D): $0.17 | 3.31% Avg Daily Range (90 D): $0.19 | 2.92% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .18M Trade Size Avg Trade Size (Sh.): 22 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 1,055 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.67M Avg Inst. Trade (90 D): $.94M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.18M Avg Closing Trade (30 D): $.65M Avg Closing Trade (90 D): $.65M Avg Closing Volume: 29.67K     News Oct 22, 2024 @ 5:00 PM Gene Therapy Clinical Trial Pipeline Gains Momentu... Source: Delveinsight Jul 22, 2024 @ 2:01 PM What's in Store for ADMA Biologics (ADMA) in Q2 Ea... Source: Zacks Equity Research Jul 19, 2024 @ 2:01 AM Adverum biotechnologies executive buys shares wort... Source: Investing.Com Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor Jul 17, 2024 @ 6:46 AM Adverum Biotechnologies Presents Positive Ixo-vec ... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.3 $-.89 $-1.5 Diluted EPS $-1.3 $-.89 $-1.5 Revenue $ 1M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -27.13M $ -18.48M $ -24.79M Operating Income / Loss $ -29.22M $ -20.88M $ -26.84M Cost of Revenue $ $ $ Net Cash Flow $ -34.47M $ -22.29M $ 74.61M PE Ratio     Splits Mar 21, 2024:   10:1